
I'm a Biotech VC, PhD Cancer Biologist, AI enthusiastic and practitioner. I write about AI, biotech, books, podcasts, and everything I learned at the intersection
| Platform | Pricing | Only free issues | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 11 | Founded | 4 months ago | Last Issue | 21 days ago |
| Active | |||||

On April 13, Revolution Medicines reported topline data from RASolute 302, the Phase 3 trial of pan-RAS inhibitor daraxonrasib monotherapy against chemotherapy in 2L metastatic pancreatic cancer patients with KRAS G12X mutations. Median OS...
Catching up with oncology is like trying to board a bullet train that left the station two years ago. Everything moves so fast. Missing one AACR → ASCO → ESMO cycle = losing the ability to cite the top-line OS/PFS/ORR bars that keep oncolog...
I typically don’t comment on model releases until I run my own evaluations. I benchmark against a set of tasks I actually care about and get an informed opinion, using my “muscle memory” from building multi-step AI agent workflows, in areas...
Before my son arrived, I had an “AI addiction” problem that consumed nearly all my free time outside of work.
A $200/month Claude Max subscription burning through $1,500+/month in API-equivalent value, with ChatGPT, Gemini, and Grok subscr...
Can AI make better decisions than humans?
Not “can AI process data” or “can AI summarize a clinical trial” or “can AI automate a tedious workflow.” We all know the answer to those.
I mean: can AI make the kind of high-stakes decisions tha...
Subscribers, engagement, traffic and sponsorship for Liang's AIxBIO foundry.
| Subscribers | Engagement | 76 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
Biotech VC, Harvard PhD in Cancer Biology, AI enthusiast and practitioner | Write about AI, biotech, books, podcasts, and everything at the intersection
You can find recent issues that have been published by Liang's AIxBIO foundry on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Liang's AIxBIO foundry, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Liang's AIxBIO foundry as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Liang's AIxBIO foundry using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Liang's AIxBIO foundry. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.